Newly FDA-Approved Kybella Erases Double-Chin Fat
Dallas, Texas (PRWEB) May 01, 2015 -- A first-in-class neckline-contouring injectable which will be marketed under the name Kybella has been approved by the FDA to reduce fat in the often difficult-to-lose “double-chin” area. Kybella is a purified synthetic version of deoxycholic acid, which is formed naturally by the body to break down dietary body fat. Micro-injections of Kybella are administered over several visits, with treatments taking fifteen to twenty minutes each. Kythera Biopharmaceuticals Inc. manufactures Kybella (formerly known as ATX-101).
Cosmetic surgeon Jeffrey Adelglass, M.D., F.A.C.S. of Dallas, Texas participated as a clinical research investigator in the Kybella clinical studies, and was selected for his extensive experience with body sculpting using permanent fat-melting medical therapies and body laser technologies.
Dr. Adelglass comments on Kybella’s FDA-approval: “I see the FDA’s approval of Kybella as confirmation that injection therapy is an effective choice for reducing problem fat areas, when it is performed in a medical environment by trained clinicians, using proven injectable mediums like Kybella.” Based on the safety and efficacy results demonstrated in these ground-breaking studies, Dr. Adelglass’ Dallas-area SKINTASTIC Cosmetic Surgery and Laser Skin Care Centers will offer Kybella to treat the submental chin and neck areas, in combination with Thermi RF and Apollo skin-tightening technologies for enhanced neck contouring results.
Similar to “Kybella-Therapy”, mesotherapy treatments are offered in spas throughout South America and Europe, involving injection of various pharmaceutical preparations, vitamins, and plant extracts that have known fat-dissolving properties. While Mesotherapy is also used to treat pockets of unwanted body fat, it has received mixed reviews in the U.S., likely due to the use of unproven therapy mediums administered in less-than-clinical settings.
“Kybella-Therapy at SKINTASTIC is performed under optimal medical conditions. Lidocaine, chilling, and tiny micro-needles can also be used for added treatment comfort,” Dr. Adelglass continues. “The best part is that Kybella-Therapy permanently dissolves the fat cells in the treatment area, no surgery needed.”
Those interested in Kybella-Therapy with Skin-Tightening can receive complimentary evaluations with Dr. Jeffrey Adelglass at SKINTASTIC Cosmetic Surgery and Laser Skin Care Centers in Dallas Uptown or Plano, Texas by calling (972) 620-3223, or by requesting an evaluation online at skintastic.com.
Media Contact: Jeffrey Adelglass, M.D., F.A.C.S. at (214) 392-8830, or jeffadel(at)gmail(dot)com. Dr. Adelglass may be available for interview to speak on advances in cosmetic surgery, new laser technologies, beauty injectables, or clinical research.
For more information about the Kybella FDA-Approval:
http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm444978.htm
Jeffrey Adelglass, M.D., F.A.C.S., SKINTASTIC Cosmetic Surgery and Laser Skin Care Centers, http://www.skintastic.com, +1 (214) 392-8830, [email protected]
Share this article